emerging
Brain Manipulation Tech
AI-driven advancements in brain-computer interfaces and deep brain stimulation are enabling personalized treatments for neurological disorders.
Timeframe
long-term
Categories
Impact areas
Detailed Analysis
Brain-computer interfaces (BCIs) are approaching commercialization, initially targeting motor-impaired patients. AI is improving the interpretation of neural signals, enhancing the potential of BCIs and deep brain stimulation for rehabilitation and communication. This is paving the way for a new category of medical and consumer brain manipulation technology, addressing conditions like depression, OCD, and ADHD.
Context Signals
Human trials of BCIs by companies like Neuralink, Synchron, and Paradromics
AI-powered personalized algorithms for deep brain stimulation
Funding of startups like Motif Neurotech, Forest Neurotech, and Neurode
Edge
Non-invasive brain stimulation devices for cognitive enhancement
Personalized brain-computer interfaces for education and training
Ethical considerations surrounding brain manipulation technology